HomeCompareSYK vs TROW

SYK vs TROW: Dividend Comparison 2026

SYK yields 1.04% · TROW yields 5.74%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TROW wins by $202.0K in total portfolio value
10 years
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →
TROW
TROW
● Live price
5.74%
Share price
$89.03
Annual div
$5.11
5Y div CAGR
38.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$245.3K
Annual income
$104,467.83
Full TROW calculator →

Portfolio growth — SYK vs TROW

📍 TROW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSYKTROW
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SYK + TROW cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SYK pays
TROW pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
TROW
Annual income on $10K today (after 15% tax)
$487.87/yr
After 10yr DRIP, annual income (after tax)
$88,797.66/yr
At 15% tax rate, TROW beats the other by $81,757.12/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYK + TROW for your $10,000?

SYK: 50%TROW: 50%
100% TROW50/50100% SYK
Portfolio after 10yr
$144.3K
Annual income
$56,375.41/yr
Blended yield
39.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SYK right now

SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
TROW
Analyst Ratings
8
Buy
24
Hold
6
Sell
Consensus: Hold
Price Target
$106.25
+19.3% upside vs current
Range: $94.00 — $115.00
Altman Z
7.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYK buys
0
TROW buys
0
No recent congressional trades found for SYK or TROW in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSYKTROW
Forward yield1.04%5.74%
Annual dividend / share$3.40$5.11
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.2%38.2%
Portfolio after 10y$43.3K$245.3K
Annual income after 10y$8,282.98$104,467.83
Total dividends collected$21.0K$207.9K
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyHold
Analyst price target$428.67$106.25

Year-by-year: SYK vs TROW ($10,000, DRIP)

YearSYK PortfolioSYK Income/yrTROW PortfolioTROW Income/yrGap
1← crossover$10,852$152.43$11,493$793.22$641.00TROW
2$11,838$226.03$13,475$1,177.49$1.6KTROW
3$13,004$336.89$16,202$1,783.11$3.2KTROW
4$14,420$505.63$20,105$2,769.00$5.7KTROW
5$16,195$766.09$25,950$4,438.01$9.8KTROW
6$18,504$1,175.64$35,165$7,398.65$16.7KTROW
7$21,635$1,835.40$50,576$12,949.45$28.9KTROW
8$26,082$2,932.10$78,172$24,055.20$52.1KTROW
9$32,737$4,829.68$131,665$48,021.60$98.9KTROW
10$43,312$8,282.98$245,350$104,467.83$202.0KTROW

SYK vs TROW: Complete Analysis 2026

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →

TROWStock

T. Rowe Price Group, Inc. is a publicly owned investment manager. The firm provides its services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions. It launches and manages equity and fixed income mutual funds. The firm invests in the public equity and fixed income markets across the globe. It employs fundamental and quantitative analysis with a bottom-up approach. The firm utilizes in-house and external research to make its investments. It employs socially responsible investing with a focus on environmental, social, and governance issues. It makes investment in late-stage venture capital transactions and usually invests between $3 million and $5 million. The firm was previously known as T. Rowe Group, Inc. and T. Rowe Price Associates, Inc. T. Rowe Price Group, Inc. was founded in 1937 and is based in Baltimore, Maryland, with additional offices in Colorado Springs, Colorado; Owings Mills, Maryland; San Francisco, California; New York, New York; Philadelphia, Pennsylvania; Tampa, Florida; Toronto, Ontario; Hellerup, Denmark; Amsterdam, The Netherlands; Luxembourg, Grand Duchy of Luxembourg; Zurich, Switzerland; Dubai, United Arab Emirates; London, United Kingdom; Sydney, New South Wales; Hong Kong; Tokyo, Japan; Singapore; Frankfurt, Germany, Madrid, Spain, Milan, Italy, Stockholm, Sweden, Melbourne, Australia, and Amsterdam, Netherlands.

Full TROW Calculator →
📬

Get this SYK vs TROW comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYK vs SCHDSYK vs JEPISYK vs OSYK vs KOSYK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.